Mark Grier

Scientific Advisor

Scientific leader in biotechnology organizations of +18 years in the pharmaceutical industry with a strong track record of research and development at all stages of drug discovery that includes proof of concept determination, early stage hit compound elucidation, lead compound optimization, and candidate preclinical & process development. Demonstrated ability to execute and complete innovative research programs to transform discoveries into pharmaceutical assets. Innovative problem solver known for approaching projects creatively, effectively prioritizing company goals, and continuous learning. A leader of diverse personalities that inspires exceptional performance from both internal and external team members.